生達化學製藥股份有限公司
生達化學製藥股份有限公司（Standard Chemical & Pharmaceutical Co., Ltd.）及其子公司在台灣及國際市場製造銷售中西藥品、化妝品及營養補充品。產品涵蓋心血管、代謝及消化系統藥物。此外研發生產原料藥、生物農藥及肥料。公司成立於 1967 年，總部位於台灣台南。
該股 RSI(6) 為 37.2，處於中性區間，短線無明顯超買超賣訊號。股價站上5日均線，跌破20日、60日、120日均線。短中期均線呈空頭排列，趨勢偏空。KD 指標中性（K=32.1）；MACD 柱狀體為負值，空方動能持續。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 08-10 | -282 | 0 | +1 | -281 |
| 08-07 | +138 | 0 | +6 | +144 |
| 08-06 | +321 | 0 | -7 | +314 |
| 08-05 | -31 | 0 | -4 | -35 |
| 08-04 | -171 | 0 | -33 | -204 |
| 08-03 | +10 | 0 | -22 | -11 |
| 07-31 | -104 | +1 | +3 | -100 |
| 07-30 | +24 | 0 | -19 | +5 |
| 07-29 | +294 | 0 | +2 | +296 |
| 07-28 | +131 | 0 | +15 | +146 |
| 07-27 | +158 | 0 | +4 | +162 |
| 07-24 | +11 | 0 | +3 | +14 |
| 07-23 | -374 | 0 | +21 | -353 |
| 07-22 | -232 | 0 | -34 | -266 |
| 07-21 | -7 | 0 | -4 | -11 |
| 07-20 | +71 | 0 | +17 | +88 |
| 07-17 | -57 | +4 | +1 | -52 |
| 07-16 | +26 | 0 | +2 | +28 |
| 07-15 | +51 | -2 | -3 | +46 |
| 07-14 | +30 | 0 | +5 | +35 |
| 07-13 | +83 | 0 | -1 | +82 |
| 07-09 | +1 | 0 | 0 | +1 |
| 07-08 | -94 | 0 | +1 | -93 |
| 07-07 | -9 | 0 | +8 | -1 |
| 07-06 | +8 | 0 | 0 | +8 |
| 07-03 | +237 | +1 | -3 | +235 |
| 07-02 | -2 | 0 | 0 | -2 |
| 07-01 | -1 | 0 | -3 | -4 |
| 06-30 | -66 | 0 | -1 | -67 |
| 06-29 | +39 | +1 | 0 | +40 |
| 06-26 | -67 | 0 | +5 | -62 |
| 06-25 | +65 | 0 | -2 | +63 |
| 06-24 | +126 | 0 | -1 | +125 |
| 06-22 | -131 | 0 | 0 | -131 |
| 06-18 | -30 | 0 | +6 | -24 |
| 06-17 | -14 | 0 | +2 | -12 |
| 06-16 | -17 | 0 | -3 | -20 |
| 06-15 | +44 | 0 | +3 | +47 |
| 06-12 | +46 | 0 | 0 | +46 |
| 06-10 | -2 | 0 | +7 | +5 |
| 06-09 | +41 | 0 | -4 | +37 |
| 06-08 | +294 | 0 | -9 | +285 |
| 06-04 | +156 | 0 | 0 | +156 |
| 06-03 | -73 | 0 | +1 | -72 |
| 06-02 | +83 | 0 | -3 | +80 |
| 06-01 | +126 | 0 | +2 | +128 |
| 05-29 | +45 | 0 | +4 | +49 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/06 | 6.15 億 | +5.9% | +9.1% |
| 2026/05 | 5.81 億 | -14.2% | -5.0% |
| 2026/04 | 6.77 億 | +18.8% | +3.8% |
| 2026/03 | 5.70 億 | +22.3% | +2.8% |
| 2026/02 | 4.66 億 | -24.2% | -16.4% |
| 2026/01 | 6.15 億 | +8.7% | +16.6% |
| 2025/12 | 5.66 億 | -2.1% | +4.8% |
| 2025/11 | 5.78 億 | -9.9% | -2.9% |
| 2025/10 | 6.41 億 | +1.9% | +19.4% |
| 2025/09 | 6.29 億 | +8.8% | +9.0% |
| 2025/08 | 5.79 億 | +3.1% | -2.3% |
| 2025/07 | 5.62 億 | - | -2.1% |